Amplia Therapeutics Limited Stock
Stocks
ATX
AU0000023822
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1100 AUD | 0.00% |
|
-8.33% | -26.67% |
| 05-29 | Amplia Therapeutics Limited Reports Earnings Results for the Full Year Ended March 31, 2026 | CI |
| 05-28 | Amplia Therapeutics Limited Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 56.46M 39.83M 34.4M 31.7M 29.67M 55.6M 3.79B 374M 146M 1.84B 149M 146M 6.38B | P/E Ratio 2027 * |
-4.78x | P/E Ratio 2028 * | -18.3x |
|---|---|---|---|---|---|
| Enterprise Value | 40.96M 28.89M 24.95M 23M 21.53M 40.34M 2.75B 272M 106M 1.34B 108M 106M 4.63B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 3.5x |
| Free-Float |
84.81% | Yield 2027 * |
-
| Yield 2028 * | - |
| 1 week | -8.33% | ||
| Current month | -18.52% | ||
| 1 month | -26.67% | ||
| 3 months | -4.35% | ||
| 6 months | -15.38% | ||
| Current year | -26.67% |
| 1 week | 0.11 |  | 0.12 |
| 1 month | 0.11 | | 0.16 |
| Current year | 0.1 | | 0.28 |
| 1 year | 0.06 | | 0.42 |
| 3 years | 0.05 | | 0.42 |
| 5 years | 0.05 | | 0.42 |
| 10 years | 0.04 | | 18.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2022-12-04 | |
Hamish George
DFI | Director of Finance/CFO | - | 2021-09-30 |
Jason Lickliter
CTO | Chief Tech/Sci/R&D Officer | - | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Peach
BRD | Director/Board Member | 70 | 2015-09-01 |
Warwick Tong
CHM | Chairman | - | 2018-05-24 |
Jane Bell
BRD | Director/Board Member | - | 2021-04-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-09-07 | Buy | Chairman | 152,174 | 0.0392% | ||
| 25-09-07 | Buy | Chairman | 336,826 | 0.0868% | ||
| 25-09-07 | Fiscal year | Founder | 535,000 | 0.1379% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -8.33% | +92.98% | +34.15% | 39.83M | |
| +1.03% | +2.30% | +55.91% | +114.22% | 56.42B | |
| +2.72% | +3.26% | +46.05% | +44.91% | 44.54B | |
| +1.12% | +2.79% | -15.04% | -21.68% | 22.9B | |
| +1.17% | +3.85% | -0.89% | +403.86% | 21.21B | |
| +3.81% | -5.07% | +11.00% | -30.62% | 16.4B | |
| +0.15% | +2.24% | +9.32% | -39.30% | 15.4B | |
| -0.69% | +0.82% | +27.75% | +176.72% | 13.35B | |
| +5.27% | +5.54% | +19.65% | - | 12.36B | |
| +1.61% | +1.28% | +95.75% | +205.26% | 11.15B | |
| Average | +1.62% | +1.05% | +34.25% | +98.61% | 21.38B | |
| Weighted average by Cap. | +1.72% | +2.36% | +32.05% | +99.58% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 10M 7.05M 6.09M 5.61M 5.25M 9.85M 670M 66.28M 25.84M 326M 26.47M 25.91M 1.13B |
| Net income | -11.6M -8.18M -7.07M -6.51M -6.1M -11.42M -778M -76.89M -29.98M -379M -30.71M -30.05M -1.31B | -3.6M -2.54M -2.19M -2.02M -1.89M -3.55M -241M -23.86M -9.3M -117M -9.53M -9.33M -407M |
| Net Debt | -15.5M -10.93M -9.44M -8.7M -8.14M -15.26M -1.04B -103M -40.06M -506M -41.03M -40.16M -1.75B | -21.5M -15.16M -13.1M -12.07M -11.3M -21.17M -1.44B -143M -55.56M -702M -56.91M -55.7M -2.43B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 0.1100 $ | 0.00% | 970,140 |
| 26-06-11 | 0.1100 $ | 0.00% | 1,909,628 |
| 26-06-10 | 0.1100 $ | -4.35% | 832,686 |
| 26-06-09 | 0.1150 $ | -4.17% | 567,133 |
| 26-06-05 | 0.1200 $ | 0.00% | 947,854 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1100AUD
Average target price
0.4200AUD
Spread / Average Target
+281.82%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATX Stock
Select your edition
All financial news and data tailored to specific country editions
